Sponsor Pipeline

Kedrion S.p.A. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
2
Recruiting
4
Phase 3
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-25 NCT07059000
A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic…
date change Primary completion pushed: 2026-08 -> 2026-12
2026-07-25 NCT07059000
A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic…
date change Completion pushed: 2026-08 -> 2027-01
Active Trials by Phase
Phase 3
4
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06752356 A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% KIg10 (QIVIGY)… Chronic Inflammatory Demyelinating Polyneuropathy Recruiting
NCT07059000 A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic… Chronic Primary Immune Thrombocytopenia (ITP) Recruiting
NCT04944979 Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric… Primary Immunodeficiency Disease Active, Not Recruiting
NCT07552987 A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff… Stiff Person Syndrome Not Yet Recruiting
Get alerts when Kedrion S.p.A.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free